RxDoctor Payments Data

Victoria Hale, MD

Family Medicine · Dandridge, TNNPI 1457989089

Payments from drug & device makers

$1,946in general payments, 2019–2025

Across 111 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$322
  • Novo Nordisk$319
  • AstraZeneca$253
  • Lilly USA, LLC$132
  • AbbVie$117
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$107
  • plus $695 from 21 others

What the payments were for

  • Food & beverage$1,946100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,946 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$74,828
Medicare patients
247
Services billed
2,359

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide44$49,100
FarxigaDapagliflozin Propanediol39$35,554
EliquisApixaban33$33,862
TrulicityDulaglutide25$23,964
JardianceEmpagliflozin18$20,345
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$20,140
OzempicSemaglutide13$17,833
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$12,264
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$3,342
Albuterol Sulfate HfaAlbuterol Sulfate91$1,724
Atorvastatin Calcium123$1,131
Buspirone Hcl42$904
Pregabalin40$894
Duloxetine Hcl41$815
Omeprazole61$786

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$132$73,06469 claims
AstraZenecaFarxiga, Breztri Aerosphere$253$47,81856 claims
PfizerEliquis$105$33,86233 claims
Boehringer IngelheimJardiance$35$20,34518 claims
GSKTrelegy Ellipta$322$20,14031 claims
Novo NordiskOzempic$319$17,83313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Dandridge

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →